Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), an antitumor protein, can trigger death receptors, including DR5 and DR4, to induce apoptosis of cancer cells at low nanomolar concentrations. The gene discussed is TNFSF10; the disease is cancer.